Welcome back to The Battery Buildout.
Below is the frame for our “Battery Bigafactory Building Practice” series:
Part 1 | Part 2 | Part 3 | Part 4 | Part 5 |
|---|---|---|---|---|
01 Overview | 09 Equipment selection & capacity | 14 FAT/SAT strategy | ||
02 Cell blueprint & capacity | 10 URS & technical agreement | 15 Equipment manufacturing supervision | ||
03 Process route & yield target | 11 Long-lead equipment & logistics | 16 FAT test matrix & acceptance | ||
04 Slurry rheology & electrode | 12 IT/OT, MES backbone arch. | 17 SAT & Line Handover | ||
05 Material & energy balance | 13 BIM & digital twin | 18 Trial Materials, spare parts & change management | ||
06 Layout & compliance | / | / | ||
07 Micro-environment | / | / | ||
08 Safety control loop | / | / |
We have discussed above 17 episodes, this edition (episode 18) closes Part 3 by addressing the three elements that determine whether the factory can transition from “commissioned” to “producing”: trial materials, spare parts, and the change/documentation handover that makes the factory operable by the people who will run it.
Table of Contents
1. Trial Materials Are Not a Purchasing Line Item. They Are a Ramp-Up Investment.
Let’s start from trial materials, commissioning consumes materials at a rate that is disproportionate to output. During commissioning and early ramp-up, reject rates are often at their highest, making financial exposure significantly elevated.
The strategic implication is that trial material procurement must be planned as a ramp-up investment, not as a procurement afterthought. The budget shall account for:
Cathode and anode active materials at production grade, not testing samples
Separator, electrolyte, and current collector foils in quantities sufficient for repeated commissioning cycles
Sacrificial material for the stages before real production material is committed
Waste handling and recycling for the scrap generated during qualification
A factory that under-budgets trial materials will face a choice during commissioning: continue testing with insufficient material and delay ramp-up, or purchase material at spot prices under schedule pressure. Neither option is attractive. The first delays revenue. The second inflates cost.
Above we discussed trial materials, then how about the Spare Parts?
2. Spare Parts: The Difference Between a Maintenance Event and a Production Crisis
In an overseas gigafactory, spare parts availability is not a maintenance convenience. It is a production continuity requirement. The distance between the factory and the equipment supplier’s spare parts warehouse is measured not in kilometres but in weeks of lead time. A part that is available on the shelf turns a two-hour repair into a two-hour repair, but a part that must be ordered, manufactured, and shipped turns a two-hour repair into a two-week production stoppage.
Is that enough if we have considered the spare parts unavailability? No, spare parts may be out of stock during sudden failures, posing the risk of long-term downtime losses. So we need also consider the predictive maintenance platform, research shows that a platform include precision spare parts control have demonstrated measurable results: out-of-stock risk reduced by 30%, and unplanned downtime reduced by 35%.
So the spare parts list is not a document to be assembled after commissioning. It is a deliverable that must be specified in the equipment contract, verified during FAT, and received with the equipment. A machine delivered without a complete spare parts list and a documented stocking strategy is not a machine that can be maintained.
Except above, there would be many engineering changes, how we can handle them?